Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 608.00
Bid: 610.00
Ask: 616.00
Change: -8.00 (-1.30%)
Spread: 6.00 (0.984%)
Open: 616.00
High: 628.00
Low: 608.00
Prev. Close: 616.00
PRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Feb 2014 10:08

RNS Number : 1138Z
Porvair PLC
03 February 2014
 

FOR IMMEDIATE RELEASE

 

 

 

Porvair plc ("Porvair" or the "Company")

Directors' Shareholdings and Issue of Equity

The Company was notified on 31 January 2014 of the following exercises of options over ordinary Porvair shares of 2 pence each ("Porvair Shares") on the same date by Ben Stocks, Chief Executive Officer, and Chris Tyler, Group Finance Director, pursuant to the Company's share option schemes.

Director

Scheme

Year of grant

Exercise price

Options exercised

Ben Stocks

LTSP 2008

2011

2p

250,000

Chris Tyler

LTSP 2008

2011

2p

175,000

On the same date, the Company was notified that on such date, Ben Stocks sold 200,000 of these new Porvair Shares at a price of 285 pence per share and Chris Tyler sold 85,000 new Porvair Shares at a price of 285 pence per share in order to meet the cost of exercise, the personal taxation liabilities arising on the options and, in the case of Ben Stocks, certain other financial commitments.

The Company was notified on 25 September 2013 of the following purchases of Ordinary Shares by Andrew Walker and Ben Stocks respectively, pursuant to the Company's dividend reinvestment plan.

Director

Date of purchase

Number of Porvair shares purchased

Purchase price

Andrew Walker

6 September 2013

19

249p

Ben Stocks

6 September 2013

1,794

249p

Following these dealings, the Directors' holdings in Porvair shares have increased. Ben Stocks is interested in 491,502 Porvair Shares, representing approximately 1.1 per cent. of the Company's issued share capital, Chris Tyler is interested in 342,450 Porvair Shares, representing approximately 0.8 per cent. of the Company's issued share capital and Andrew Walker is interested in 29,499 Porvair Shares, representing approximately 0.1 per cent. of the Company's issued share capital.

As a result of the exercise of the options noted above, the Company has, on 31 January 2014, issued in aggregate 425,000 new Porvair Shares. Following the issue of the new Porvair Shares, the Company will have 44,158,598 ordinary shares in issue. There are no Porvair Shares held in treasury.

Therefore, the total number of voting rights in the Company is 44,158,598. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

 

Peel Hunt LLP 020 7418 8900

Daniel Harris

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGMGGZGFNGDZM
Date   Source Headline
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.